BUTETHAL--DEA SCHEDULE III ITEM

Absorption

Rapidly absorbed following oral administration.

Toxicity

Signs of overdose include confusion (severe), decrease in or loss of reflexes, drowsiness (severe), fever, irritability (continuing), low body temperature, poor judgment, shortness of breath or slow or troubled breathing, slow heartbeat, slurred speech, staggering, trouble in sleeping, unusual movements of the eyes, weakness (severe).

The Uses of BUTETHAL--DEA SCHEDULE III ITEM

BUTETHAL--DEA SCHEDULE III ITEM is a barbiturate derivative that is used as a hypnotic agent with sedative and anticonvulsant properties. BUTETHAL--DEA SCHEDULE III ITEM is a Controlled Substance.

Background

Butobarbital is a sedative and a hypnotic drug.

Indications

For the treatment of insomnia.

Definition

ChEBI: Butobarbital is a member of barbiturates.

brand name

Neonal (Abbott).

Pharmacokinetics

Butethal (also known as butobarbitone and butobarbital) belongs to a group of medicines called the barbiturates. It is thought to act on receptors in the brain (GABA receptors) causing the release of the chemical GABA. This chemical inhibits certain areas of the brain resulting in sleepiness.

Metabolism

Hepatic.